| Mechanisms of immunopathogenesis in cutaneous leishmaniasis and post kala-azar dermal leishmaniasis (PKDL) G Volpedo, T Pacheco-Fernandez, EA Holcomb, N Cipriano, B Cox, ... Frontiers in cellular and infection microbiology 11, 685296, 2021 | 73 | 2021 |
| Ibrutinib treatment inhibits breast cancer progression and metastasis by inducing conversion of myeloid-derived suppressor cells to dendritic cells S Varikuti, B Singh, G Volpedo, DK Ahirwar, BK Jha, N Saljoughian, ... British Journal of Cancer 122 (7), 1005-1013, 2020 | 66 | 2020 |
| From infection to vaccination: reviewing the global burden, history of vaccine development, and recurring challenges in global leishmaniasis protection G Volpedo, RH Huston, EA Holcomb, T Pacheco-Fernandez, ... Expert review of vaccines 20 (11), 1431-1446, 2021 | 46 | 2021 |
| One-to-one play promotes numerical equivalence concepts KS Mix, JA Moore, E Holcomb Journal of cognition and development 12 (4), 463-480, 2011 | 26 | 2011 |
| Centrin-deficient Leishmania mexicana confers protection against New World cutaneous leishmaniasis G Volpedo, T Pacheco-Fernandez, EA Holcomb, WW Zhang, ... NPJ vaccines 7 (1), 32, 2022 | 25 | 2022 |
| MicroRNA-21 deficiency promotes the early Th1 immune response and resistance toward visceral leishmaniasis S Varikuti, C Verma, E Holcomb, BK Jha, A Viana, R Maryala, F Lamenza, ... The Journal of Immunology 207 (5), 1322-1332, 2021 | 23 | 2021 |
| The role of vascular endothelium and exosomes in human protozoan parasitic diseases S Varikuti, BK Jha, EA Holcomb, JC McDaniel, M Karpurapu, N Srivastava, ... Vessel plus 4, 2020 | 15 | 2020 |
| Updates in combined approaches of radiotherapy and immune checkpoint inhibitors for the treatment of breast cancer KM Jungles, EA Holcomb, AN Pearson, KR Jungles, CR Bishop, ... Frontiers in Oncology 12, 1022542, 2022 | 14 | 2022 |
| High-content CRISPR screening in tumor immunology EA Holcomb, AN Pearson, KM Jungles, A Tate, J James, L Jiang, ... Frontiers in Immunology 13, 1041451, 2022 | 11 | 2022 |
| A forced marriage of IL-2 and PD-1 antibody nurtures tumor-infiltrating T cells EA Holcomb, W Zou The Journal of Clinical Investigation 132 (3), 2022 | 5 | 2022 |
| Centrin-deficient Leishmania mexicana confers protection against New World cutaneous leishmaniasis. NPJ Vaccines 7, 32 G Volpedo, T Pacheco-Fernandez, EA Holcomb, WW Zhang, ... | 5 | 2022 |
| Potentiating the radiation-induced type I interferon antitumoral immune response by ATM inhibition in pancreatic cancer Q Zhang, L Jiang, W Wang, AK Huber, VM Valvo, KM Jungles, ... JCI insight 9 (6), 2024 | 2 | 2024 |
| Impact of immune tolerance mechanisms on the efficacy of immunotherapy in primary and secondary liver cancers K Sankar, AN Pearson, T Worlikar, MD Perricone, EA Holcomb, ... Translational Gastroenterology and Hepatology 8, 2023 | 2 | 2023 |
| SLC4A11 mediates ammonia import and promotes cancer stemness in hepatocellular carcinoma AL Elaimy, MO El-Derany, J James, Z Wang, AN Pearson, EA Holcomb, ... bioRxiv, 2024.08. 06.606899, 2024 | | 2024 |
| Liver Metastases Potentiate Cancer Progression AN Pearson, E Holcomb, J James, KM Jungles, N Nedzesky, G Schaefer, ... The Journal of Immunology 210 (1_Supplement), 88.09-88.09, 2023 | | 2023 |
| The radiosensitizing effects of monopolar spindle kinase I in syngeneic models of triple negative breast cancer and its implications on the tumor immune microenvironment KM Jungles, Z Wang, C Bishop, KR Jungles, C Wilson, M Liu, AN Pearson, ... The Journal of Immunology 210 (1_Supplement), 245.06-245.06, 2023 | | 2023 |
| CRISPR-Cas9 screen identifies potential novel regulators of CD8+ T cell dysfunction EA Holcomb, L Jiang, A Tate, AN Pearson, Z Wang, KM Jungles, J James, ... The Journal of Immunology 210 (1_Supplement), 86.13-86.13, 2023 | | 2023 |
| Targeting monopolar spindle kinase I (TTK) as a radiosensitizing strategy in syngeneic murine models of triple negative breast cancer (TNBC) and its implications on the tumor … KM Jungles, Z Wang, CR Bishop, KR Jungles, C Wilson, M Liu, ... Cancer Research 83 (7_Supplement), 2823-2823, 2023 | | 2023 |
